Scientific Program

  • Wednesday, September 23
  • Thursday, September 24
  • Friday, September 25

Wednesday, September 23

[SY1B]
Hospital transfusion management

Safe and appropriate use of blood products is very important in a blood transfusion. According to the addition of the paragraph regarding the establishment and operation of the Hospital Transfusion Committee and the Blood Transfusion Management Office in hospitals to the Korean Blood Management Act, these mandatories will be implemented from December 2020, and hospitals that perform blood transfusions need to be prepared. The goal of the session is to help hospitals to prepare countermeasures.

Date & Time Sept. 23 (Wed), 10:30-12:00 Venue Room B Language Kor
Speaker(s)
  1. How to implement blood transfusion management office?
    Sinyoung Kim, Yonsei University College of Medicine, Korea
  2. Transfusion committee and patient blood management
    Tae Hyun Um, Inje University Ilsan Paik Hospital, Korea
  3. The roles of transfusion specialist in blood management
    Hyung Hoi Kim, Pusan National University School of Medicine, Korea
  4. Managing hospital transfusion committees in small to midsize hospitals
    Seon Joo Kang, DAVOS Hospital, Korea

[SY1C]
Policy trends in laboratory medicine

In this session, current policy issues related to laboratory medicines, will be introduced and discussed. Those issues are approval of national reference laboratory for infectious diseases, the third revision of relative value score, and exemption of informed consent in collecting residual samples for research.

Date & Time Sept. 23 (Wed), 10:30-12:00 Venue Room C Language Kor
Speaker(s)
  1. Accreditation system for national reference laboratories for infectious diseases
    Jae-Sun Park, Korea Centers for Disease Control and Prevention, Korea
  2. 3rd Reorganization of the resource-based relative value scale (RBRVS)
    Woochang Lee, University of Ulsan College of Medicine, Korea
  3. Exemption of informed consent in collecting residual samples for research
    Sang Hoon Song, Seoul National University College of Medicine, Korea

[EW1A]
Roche Diagnostics Korea:

Date & Time Sept. 23 (Wed.), 12:00-13:00 Venue Room A
(Premier A+B)
Language Eng

[EW1B]
Abbott Laboratories: Clostridioides difficile Infection (CDI): The Challenge, the tests, and the guidelines

This workshop will focus on different testing methodologies to detect C. difficile Infection and explain how they have been adopted in guidelines and clinical practice

Date & Time Sept. 23 (Wed.), 12:00-13:00 Venue Room B
(Premier C)
Language Eng
Speaker(s)
  1. Diagnostic algorithm for rapid and cost-effective detection of C. difficile infection: Comparison of the C. DIFF QUIK CHEK COMPLETE and VIDAS GDH & toxin assay
    Dong Hee Whang, Inje University College of Medicine, Korea
  2. Clostridioides difficile Infection (CDI): The challenge, the tests, and the guidelines
    David M. Lyerly, TECHLAB, Inc, USA

[EW1C]
Sysmex Korea: Nearing 360° in Haemostasis Testing: Latest Developments from Sysmex

1) Performance Evaluation of CN-6000 a new Automated Hemostasis Analyzer. First-hand Experience from a Hemostasis lab.
2) CN-Series Hemostasis Analyzers Including an Integrated Chemiluminescent Enzyme Immunoassay Testing Capability

Date & Time Sept. 23 (Wed.), 12:00-13:00 Venue Room C
(Room 116-118)
Language Eng
Speaker(s)
  1. Performance Evaluation of CN-6000 a new Automated Haemostasis Analyser. First-hand Experience From a Haemostasis lab.
    Steve Kitchen, Royal Hallamshire Hospital, UK
  2. CN-Series Haemostasis Analysers Including an Integrated Chemiluminescent Enzyme Immunoassay Testing Capability.
    Chris Gardiner, Chris Gardiner Consulting Ltd, UK

[EW1D]
Beckman Coulter Korea: Performance evaluation of Beckman Coulter Access hsTnI in Korean population

Defining the analytical performance and reference limits of cardiac troponin I is critical because it is clinically important in determining myocardial injury, and is variable among reagents, age, sex or races.

Date & Time Sept. 23 (Wed.), 12:00-13:00 Venue Room D
(Room 113-115)
Language Eng
Speaker(s)
  1. Performance evaluation of Beckman Coulter Access hsTnI in Korean population
    Soojin Yoo, Paik Hospital, Inje University, Korea

[SY2A]
Improving laboratory productivity through IT system

Clinical laboratory continues to improve in productivity with the development of technology. One of the most important factor in laboratory productivity is IT system. Laboratory can handle large amounts of data and information quickly and easily with advanced it system. We're not IT professionals, so the IT still sounds like a distant talk, and it feels like a difficult area to accomplish. With this session, we would like to share experiences and explore the new technology.

Date & Time Sept. 23 (Wed), 13:00-14:30 Venue Room A Language Kor
Speaker(s)
  1. Laboratory Information System (LIS): Introduction and experience
    Jae Hoon Choi, EONE Laboratories, Korea
  2. The case of new IT technologies in laboratory medicine
    Soohyun Kim, Seegene Medical Foundation, Korea
  3. Making artificial intelligence real in laboratory medicine
    HackJin Lee, DoAI Inc., Korea
  4. Experience of AI system development in laboratory medicine
    Eun-Hae Cho, GC Genome, Korea

[SY2B]
Education workshop for residents and new specialists in laboratory medicine

This session is intended for residents in training, new starters, or laboratory medicine specialists with interests of basic knowledge. We will be covering the very basics and practical aspects of laboratory medicine in the fields of laboratory management, clinical chemistry, diagnostic hematology, and clinical microbiology.

Date & Time Sept. 23 (Wed), 13:00-14:30 Venue Room B Language Kor
Speaker(s)
  1. Laboratory management & continuous quality improvement
    Woo In Lee, Kyung Hee University School of Medicine, Korea
  2. Therapeutic drug monitoring
    Soo-Youn Lee, Sungkyunkwan University School of Medicine, Korea
  3. Laboratory investigations for bleeding disorders
    Sung Ran Cho, Ajou University School of Medicine, Korea
  4. Rapid diagnostic tests in clinical microbiology laboratory
    Yu Kyung Kim, Kyungpook National University School of Medicine, Korea

[SY2C]
Education course for laboratory medicine specialist

This session is an essential education program to qualify as a laboratory medicine specialist. And the program covers the whole of the laboratory management, evaluation of resident training and laboratory information necessary for instruction of residents.

Date & Time Sept. 23 (Wed), 13:00-17:00 Venue Room C Language Kor
Speaker(s)
  1. Qualification and role of resident training staff
    Yongjung Park, Yonsei University College of Medicine, Korea
  2. Participation in Multidisciplinary Care by the Laboratory Physician
    Saeam Shin, Yonsei University College of Medicine, Korea
  3. The role of clinical pathologist in the laboratory management
    Sung-Eun Cho, LabGenomics Clinical Laboratories, Korea
  4. Maintenance and function checks for laboratory equipment
    Eun-Jung Cho, Hallym University College of Medicine, Korea
  5. Performance evaluation protocols of laboratory measurement procedures for laboratory medicine specialist
    Tae-Dong Jeong, Ewha Womans University College of Medicine, Korea
  6. Statistical internal quality control
    Sang-Guk Lee, Yonsei University College of Medicine, Korea
  7. TBD
    Yun Ji Hong, Seoul National University College of Medicine, Korea

[SY3B]
Convergent evolution of specialists in the mid-sized hospitals

This session is designed to provide specialists and residents with a good foundation knowledge in all aspects of specialist's role in the mid-sized hospitals to improve abilities to solve real-world problems.

Date & Time Sept. 23 (Wed), 14:30-15:30 Venue Room B Language Kor
Speaker(s)
  1. Proper antibiotics usage in middle sized hospital
    Youn Jeong Kim, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Korea
  2. Subclinical iron deficiency in non-anemic korean health examinees
    Eun-Hee Nah, Korea Association of Health Promotion, Korea
  3. Chief information officer (CIO) role of laboratory medicine specialist in small and medium-sized hospital
    Yung Zoon Jung, Nasaret International Hospital, Korea
  4. Desirable functionalities of laboratory information system in the mid-sized hospitals
    Hyun-Ki Kim, University of Ulsan College of Medicine, Korea

[SY4A]
Artificial intelligence for medical genetics

The development of artificial intelligence using high performance computing power is expected to be the key to solving the complex problems of medical field, which have been difficult to access. In this session, we will discuss the latest knowledge on how AI is applied and what can be achieved in medical genetics.

Date & Time Sept. 23(Wed), 15:30-17:00 Venue Room A Language Eng
Speaker(s)
  1. DNA knows your height and weight: missing heritability, interaction, and artificial intelligence
    Namshin Kim, Korea Research Institute of Bioscience & Biotechnology, Korea
  2. AI-based genomic diagnostics in cancer immunotherapy
    Jung Kyoon Choi, KAIST, Korea
  3. Genome editing using CRISPR
    Hyongbum Kim, Yonsei University College of Medicine, Korea

[SY4B]
Inspector workshop of Korean laboratory accreditation program

This workshop deals with the accreditation checklist and intends to improve understanding and practical skills required of an inspection team leader and team members.

Date & Time Sept. 23 (Wed), 15:30-17:00 Venue Room B Language Kor
Speaker(s)
  1. Molecular diagnostic assay validation in genetic disorders
    Woori Jang, Inha University School of Medicine, Korea
  2. Quality control in transfusion medicine
    Hyun-Ji Lee, Pusan National University School of Medicine, Korea
  3. Quality control in diagnostic immunology
    Hyeyoung Lee, Catholic Kwandong University College of Medicine, Korea
  4. Surveyor training program for ISQua accreditation
    Jihyang Lim, The Catholic University of Korea, College of Medicine, Korea

[PL01]

Date & Time Sept. 23 (Wed), 17:30-18:30 Venue Room A Language Eng
Chairs Sun Hoe Koo, Chungnam National University College of Medicine, Korea
Jong Hee Shin, Chonnam National University Medical School, Korea
Speaker(s)
  1. Fusobacterium nucleatum and colorectal cancer
    Kyungwon Lee, Yonsei University College of Medicine; SCL Academy, Korea

Thursday, September 24

[SY5C]
External Quality Assurance System

Date & Time Sept. 24 (Thu), 08:00-11:00 Venue Room C Language Eng
Speaker(s)
  1. Risk assessment for external quality assurance choices in clinical laboratories
    Yi-Ching Lin, College of Medicine, Kaohsiung Medical University, Taiwan
  2. External quality assurance system in clinical chemistry: Present status in India
    Praveen Sharma, Department of Biochemistry, All India Institute of Medical Sciences, India
  3. Current status of korean association of external quality assessment service and proficiency testing
    Kyunghoon Lee, Seoul National University College of Medicine, Korea
  4. Current status of external quality assurance system in japan
    Katsuo Kubono, Niigata University of Health and Welfare, Japan
  5. Implementation of national external quality assurance scheme (EQAS) to achieve harmonization of laboratory result: indonesia’s experience
    Agus Susanto Kosasih, Dharmais Hospital National Cancer Center, Indonesia
  6. Result of 12 years implementing EQA for medical laboratories in Vietnam
    Truong Quan Thuy, Center for Standardization and Quality control in Medical Lab of Ho Chi Minh City, Vietnam
  7. External quality assurance system in mongolia
    OYUNDELGER Munkhtuvshin Ertsuud, Mongolian Association of the Laboratory Medicine, Mongolia
  8. External quality assurance system in medical laboratories: Myanmar experience
    Wah Wah Aung, Advanced Molecular Research Centre, Myanmar

[SY6A]
Laboratory investigation of hormone and vitamins

In this session, we will discuss the clinical application of hormone tests used to diagnose and manage endocrine diseases and the recent update of the test methods. We will also look at diagnostic tests that can be used for differential diagnosis of vitamin B12 and folic acid deficiency.

Date & Time Sept. 24 (Thu), 08:30-10:00 Venue Room A Language Eng
Speaker(s)
  1. Vitamin B12 and folate deficiency and its laboratory investigation; Comparison of diagnostic accuracy of active B12 and total vitamin B12.
    Barnali Das, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, India
  2. Laboratory assessment in the diagnosis and management of parathyroid disease
    Soo Young Moon, Pusan National University School of Medicine, Korea
  3. Urine free cortisol in the diagnosis of cushing’s syndrome
    Jooyoung Cho, Yonsei University Wonju College of Medicine, Korea

[SY6B]
PHEIC (Public Health Emergency of International Concern) & EUA (Emergency Use Authorization)

WHO declared the COVID-19 outbreak to be a Public Health Emergency of International Concern (PHEIC) on January 30, 2020.
PHEIC is a formal declaration by the WHO of "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response".
In this session PHEIC and EUA (Emergency Use Authorization) in response to the Korea’s coronavirus outbreak will be discussed.

Date & Time Sept. 24 (Thu), 08:30-10:00 Venue Room B Language Eng
Speaker(s)
  1. PHEIC (Public Health Emergency of International Concern)
    Jeong Su Park, Seoul National University College of Medicine, Korea
  2. SARS-CoV-2 & COVID-19 in Korea
    Heungsup Sung, University of Ulsan College of Medicine, Korea
  3. EUA (Emergency Use Authorization) in Korea’s Coronavirus outbreak
    Hyukmin Lee, Yonsei University College of Medicine, Korea

[PL02]
AACC-KSLM Select Session

Date & Time Sept. 24 (Thu), 11:00-12:00 Venue Room A Language Eng
Chairs Chan-Jeoung Park, University of Ulsan College of Medicine, Korea
Junghan Song, Seoul National University College of Medicine, Korea
Speaker(s)
  1. Clinical Lab 2.0: How the laboratory can support value based care, optimize patient outcomes, and reduce total costs of care
    David G. Grenache, American Association for Clinical Chemistry, USA

[EW2A]
Roche Diagnostics Korea: Performance Evaluation and User Experience of the Roche’s Automated Coagulation Analyzer

Sharing the evaluation of Roche's cobas t711 automated coagulation analyzer and experience of operation connected to the CCM (cobas connection module).

Date & Time Sept. 24 (Thu.), 12:00-13:00 Venue Room A
(Premier A+B)
Language Eng
Speaker(s)
  1. Performance Evaluation and User Experience of the Roche’s Automated Coagulation Analyzer
    Saeam Shin, Yonsei University College of Medicine, Korea

[EW2B]
Abbott Laboratories: Global Viral Surveillance Program

Though the Global Surveillance Program, blood samples are being actively collected from 41 countries on six continents, including Laos, Thailand, Vietnam and the Philippines. The database over 60,000 samples, resulting in over 5,000 different viral sequences is the resource for designing the HIV and hepatitis diagnostic tests. The Global Surveillance Program has been established for development of “best-in-class” assays and will contribute to improve the quality and reliability of testing with continued collaboration with research and clinical foundations.

Date & Time Sept. 24 (Thu.), 12:00-13:00 Venue Room B
(Premier C)
Language Eng
Speaker(s)
  1. Global Viral Surveillance Program
    Haiyoung Jung, Abbott Diagnostics, Korea

[EW2C]
Siemens Healthcare Ltd: Laboratory Medicine & Clinical Practice Guides: Utilizing High-Sensitivity Cardiac Troponin Assays to Assist in Improved Early Diagnostics and Risk Assessment of Myocardial Injury

This workshop will address laboratory practice recommendations, along IFCC C-CB and AACC Academy guidelines, for the implementation of high-sensitivity cardiac troponin (hs-cTn) assays into clinical practice. Differentiation of myocardial injury and myocardial infarction, along the Fourth Universal Definition of Myocardial Infarction guidelines, will be discussed, and the performance of hs-cTn assays in early rule-out and rule-in algorithms will be examined.

Date & Time Sept. 24 (Thu.), 12:00-13:00 Venue Room C
(Room 116-118)
Language Eng
Speaker(s)
  1. Laboratory Medicine & Clinical Practice Guides: Utilizing High-Sensitivity Cardiac Troponin Assays to Assist in Improved Early Diagnostics and Risk Assessment of Myocardial Injury
    Pearline TEO, Asia Pacific, Siemens Healthineers, Singapore

[EW2D]
Seegene Inc.: COVID-19 : current & prospective solution

As COVID-19 has been spreading out rapidly all across the world, the rapid and accurate diagnosis is becoming more demanded. Extraction-free PCR, a novel method for shortening the assay time of RT-PCR, will be taken during the workshop to suggest more effective way of identification for COVID-19 and respiratory infection.

Date & Time Sept. 24 (Thu.), 12:00-13:00 Venue Room D
(Room 113-115)
Language Eng
Speaker(s)
  1. Multi-center study for infection statue of SARS-CoV-2 and common respiratory virus in symptomatic patients
    Hyunwoong Park, Seoul National University Boramae Medical Center, Korea

[KS01]

Date & Time Sept. 24 (Thu), 13:00-13:40 Venue Room A Language Eng
Chairs Chang-Ho Jeon, Catholic University of Daegu School of Medicine, Korea
Jong-Won Kim, Sungkyunkwan University School of Medicine, Korea
Speaker(s)
  1. Genomics, metabolomics and the diagnosis of rare diseases
    Ching-Wan Lam, The University of Hong Kong, Hong Kong

[SY7A]
AACC-KSLM Select Session
If at First You Don’t Succeed: An interactive case-based view of emerging molecular technologies.

DNA-based molecular technologies are becoming synonymous with precision medicine; however, these tests don’t have all the answers. This session will be an interactive, case-based workshop that will describe approaches to molecular test selection when front-line testing is uninformative. We will review the scientific basis and practical considerations of three emerging technologies that are increasingly used in genomic medicine: RNA-based next-generation sequencing (NGS), droplet digital PCR, and cell-free tumor DNA tests.

Date & Time Sept. 24 (Thu), 13:40-15:10 Venue Room A Language Eng
Speaker(s)
  1. What to do when you don’t have tissue: Cell-free tumor DNA
    Christina M. Lockwood, University of Washington, USA
  2. What to do when DNA fails: RNA-based next-generation sequencing
    Seung-Tae Lee, Yonsei University College of Medicine, Korea
  3. What to do when you don’t have enough: Droplet digital PCR
    Vera Ashley Paulson, University of Washington, USA

[SY7B]
Technical innovation and laboratory medicine and infection control

Infection control is multidisciplinary process and it can be deeply influenced by diagnostic stewardship. Recent innovation in laboratory medicine are helping to effectively manage infection control through rapid results reporting. In this session, the novel technique for diagnosing healthcare-associated infection will be reviewed by some experts.

Date & Time Sept. 24 (Thu), 13:40-15:40 Venue Room B Language Kor
Speaker(s)
  1. TBD
    Ki Ho Hong, Seoul Medical Center, Korea
  2. New diagnostics test for HAI in primary-care hospitals
    Hyukmin Lee, Yonsei University College of Medicine, Korea
  3. New approach to diagnosis of multidrug-resistant pathogens
    YoungJin Kim, Kyung Hee University School of Medicine, Korea
  4. The current status of C. difficile infection diagnosis; meaning of laboratory diagnosis
    Bo-Mun Shin, Inje University College of Medicine, Korea

[SY7C]
MFDS-KSLM Session
Cooperation of ministry of food and drug safety and korean society for laboratory medicine for overcoming COVID-19

COVID-19 has caused many cases and deaths in globally. It showed the great value of diagnostic tests for quarantine. We will discuss the emergency use authorization (EUA) and usual approval process of the Ministry of Food and Drug Safety (MFDS) and approval cases of other countries for exporting Korean IVD manufacturer. Also, explain the clinical evaluation procedure and the institute of clinical performance test in accordance with act and regulations for IVD.

Date & Time Sept. 24 (Thu), 13:40-15:10 Venue Room C Language Kor
Speaker(s)
  1. Major subjects of IVD regulations and designation for the institute of clinical performance test
    Seung Yong Lee, Ministry of Food and Drug Safety, Korea
  2. Process of Emergency Use Authorization (EUA) in Korea and other countries
    Kyoung Ho Roh, National Health Insurance Service Ilsan Hospital, Korea
  3. Experience of COVID-19 IVD approval for each country
    Jinkoo Kang, Seegene co., Korea
  4. Regulation and process of clinical performance test for IVD approval
    Young-Wook Ahn, National Institute of Food and Drug Safety Evaluation, Korea

[SY8A]
KCDC-KSLM Session
Preparedness and rapid response against pandemic COVID-19 in South Korea

Coronavirus infectious disease-19 (COVID-19) started as local outbreak in Wuhan, China but widely disseminated and developed into a worldwide pandemic. The response to emerging infectious diseases is based on the prevention or mitigation policy implemented based on prompt research in various fields, and the development of new diagnostic methods is the one of essential component in managing this novel infection by accurate diagnosis to blocks transmission. In this section, we introduced the process for the development and application of diagnostic methods to respond emerging infectious diseases in South Korea.

Date & Time Sept. 24 (Thu), 16:00-17:30 Venue Room A Language Eng
Speaker(s)
  1. Laboratory response for COVID019 in Korea: Lessons from the past
    Gab Jung Kim, Korea Centers for Disease Control and Prevention, Korea
  2. Laboratory response for COVID019 in Korea: For future 2nd wave
    Hyukmin Lee, Yonsei University College of Medicine, Korea
  3. Genome-wide characterization of point mutations in SARS-CoV-2 Genome
    Jun-Sub Kim, Korea Centers for Disease Control and Prevention, Korea
  4. Problem solving in SARS-CoV-2 molecular testing
    Heungsup Sung, University of Ulsan College of Medicine, Korea

[SY8B]
Clinically unmet needs in laboratory hematology

Diagnostics of hematologic malignancies have recently been experiencing extensive modification due to the incorporation of advanced diagnostic tools into existing workflows. In this session, we will define the role of hematopathologists in the new diagnostic era by discussing the emerging diagnostic issues in the field of hematologic malignancies.

Date & Time Sept. 24 (Thu), 16:00-17:30 Venue Room B Language Eng
Speaker(s)
  1. Next-generation sequencing and next-generation flowcytometry in diagnostics of plasma cell disorder: Is it more useful and informative for treatment in real-world clinical settings?
    Hyun-Young Kim, Sungkyunkwan University School of Medicine, Korea
  2. Diagnostics of myelodysplastic syndrome: Can the genetics open the door to perfect diagnosis?
    Young-Uk Cho, University of Ulsan College of Medicine, Korea
  3. Germline variant screening in myeloid neoplasms: Should it be routinely tested in all patients?
    Borahm Kim, Korea University College of Medicine, Korea

[KS02]

Date & Time Sept. 24 (Thu), 17:30-18:10 Venue Room A Language Eng
Chairs Kyungja Han, The Catholic University of Korea College of Medicine, Korea
Young-Jin Lee, Wonkwang University School of Medicine, Korea
Speaker(s)
  1. PML-RARA: Lessons from the chimera and the curable leukemia
    Scott C. Kogan, University of California, USA

[EW3A]
LG Chem: Quality control for semi-quantitative allergen specific Immunoglobulin E test

The types of antigens detected in serum allergy antigen specific IgE antibody tests vary widely. Since most sIgE test reagents use antigen extract as raw materials or a mixture of antigen proteins, standardization of sIgE test is difficult. Most assay reagents use heterologous interpolation to calibrate against WHO's total IgE reference materials. Therefore, to report reliable results, internal quality control and external quality assessment (EQA) is critical to ensure the accuracy and reliability of laboratory results.

Date & Time Sept. 24 (Thu.), 18:30-19:30 Venue Room A
(Premier A+B)
Language Eng
Speaker(s)
  1. Quality control for semi-quantitative allergen specific Immunoglobulin E test
    Eun-Jee Oh, College of Medicine, The Catholic University of Korea, Korea

[EW3B]
MSD: Advanced understandings for immunotherapeutic anti-cancer drug and companion diagnostics

Why is immunotherapy a promising cancer treatment?
The best and latest treatment and diagnostic option for successful immunotherapy.
Future companion diagnostics biomarkers.
How NGS test to present efficacy of IO drugs?

Date & Time Sept. 24 (Thu.), 18:30-19:30 Venue Room B
(Premier C)
Language Eng

[EW3C]
Genetree: Human papillomavirus genotyping test using Next generation sequencing technology

Date & Time Sept. 24 (Thu.), 18:30-19:30 Venue Room C
(Room 116-118)
Language Eng

Friday, September 25

[SY9C]
Evidence-based laboratory management and Its convergence with CLSI guidelines

In this session, we will explore the CLSI standards related to the evidence-based laboratory management and discuss how to apply them to actual laboratories.

Date & Time Sept. 25 (Fri), 08:30-10:00 Venue Room C Language Eng
Speaker(s)
  1. Autoverification of medical laboratory results for specific disciplines (AUTO15)
    Bill Marquardt, Vice President of Laboratory Intelligence at McKesson Laboratory Solutions, USA
  2. Measurement procedure comparison and bias estimation using patient samples (EP09)
    Jeffrey R Budd , Consulting Biostatistician, USA
  3. Preliminary evaluation of quantitative clinical laboratory measurement procedures; Approved guideline—Third Edition
    Hyewon Park, Seegene Medical Foundation, Korea

[PL03]

Date & Time Sept. 25 (Fri), 11:00-12:00 Venue Room A Language Eng
Chairs Won-Ki Min, University of Ulsan College of Medicine, Korea
Gye-Cheol Kwon, Chungnam National University College of Medicine, Korea
Speaker(s)
  1. Measurement traceability for timeless global harmonization of clinical laboratory testing
    Sang-Ryoul Park, Korea Research Institute of Standards and Science, Korea

[EW4A]
bioMérieux KOREA: Syndromic molecular testing for pneumonia: Share insight and user experience

Biofire® FilmArray® Pneumonia(PN) panel identifies 33 clinically relevant targets from sputum (including endotracheal aspirate) and bronchoalveolar lavage (including mini-BAL) samples in 1 hour.
We would like to introduce BioFire® FilmArray® Pneumonia(PN) panel and share the insight of syndromic approach and user experience.

Date & Time Sept. 25 (Fri.), 12:00-13:00 Venue Room A Language Eng

[EW4B]
Handok Inc.: Sensitive and Reliable Liquid Biopsy without Amplification

Detecting mutated genes of extremely low abundance in blood is a key for early cancer diagnosis. However, when the copy number is low (< 10 copies), the sensitivity and specificity need to be improved. A new approach utilizing atomic microscopy to overcome such hurdles will be introduced.

Date & Time Sept. 25 (Fri.), 12:00-13:00 Venue Room B Language Eng

[EW4C]
QIAGEN Korea: Update on Immune-based monitoring in Solid Organ Transplants

Date & Time Sept. 25 (Fri.), 12:00-13:00 Venue Room C Language Eng
Speaker(s)
  1. Clinical utility of QuantiFERON-CMV assay for diagnosis and monitoring of CMV infection or disease in patients undergoing transplantation
    Jeff Boyle, Global Technical Lead for QIAGEN’s Immune Monitoring Franchise

[EW4D]
SD Biosensor: Novel POC MDx Solution for SARS-CoV-2

1. Introduction: POC MDx for SARS-CoV-2
2. ‘STANDARD M10’ Features
3. ‘STANDARD M SARS-CoV-2’ and more assays
4. Applications of the STANDARD M10

Date & Time Sept. 25 (Fri.), 12:00-13:00 Venue Room D Language Eng

[KS03]

Date & Time Sept. 25 (Fri), 13:00-13:40 Venue Room A Language Eng
Chairs Jang Soo Suh, Kyungpook National University School of Medicine, Korea
Young Ae Lim, Ajou University School of Medicine, Korea
Speaker(s)
  1. New paradigms in the treatment of massive hemorrhage
    Mark Harris Yazer, Department of Pathology, University of Pittsburgh, USA

[SY10A]
Challenges to maintain an adequate blood transfusion

Due to the decline of the blood donating population and the population aging, we are in a critical situation of blood shortages. In this session, the recent advances in adequate transfusion policy in the patient side will be presented.

Date & Time Sept. 25 (Fri), 14:00-15:30 Venue Room A Language Eng
Speaker(s)
  1. Physiology of anemia and oxygen delivery
    Jun Ho Jang, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea
  2. Liberal or restrictive transfusion, that is a question
    Young-Woo Kim, National Cancer Center Graduate School of Cancer Science and Policy, Korea
  3. Role of a clinical pathologist for blood shortages
    Dong Wook Jekarl, College of Medicine, The Catholic University of Korea, Korea

[SY10B]
Practical aspects of laboratory management (Ⅷ); Clinical laboratory environment and safety

The “Laboratory Management Committee’ will introduce the ‘Clinical Laboratory Environment and Safety’, which are the basic elements for Systematic Laboratory Management.

Date & Time Sept. 25 (Fri), 14:00-15:30 Venue Room B Language Eng
Speaker(s)
  1. Management of reagent water and clinical laboratory waste
    Younhee Park, Yonsei University College of Medicine, Korea
  2. Management of hazardous chemicals
    Kyoung Ho Roh, National Health Insurance Service Ilsan Hospital, Korea
  3. Clinical laboratory safety in COVID-19 test
    Chang-Ki Kim, Seoul Clinical Laboratories (SCL), Korea

[SY10C]
CAP

The challenge of laboratory-developed tests: a regulatory and legislative update

Date & Time Sept. 25 (Fri), 14:00-15:30 Venue Room C Language Eng
Speaker(s)